市場調査レポート

商品コード

1629605

僧帽弁疾患市場：治療タイプ別、適応症別、デバイスタイプ別、エンドユーザー別、地域別

Mitral Valve Disease Market, By Treatment Type, By Indication, By Device Type, By End User, By Geography

出版日: 2024年12月04日
発行: Coherent Market Insights
ページ情報: 英文 167 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 661,455円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,028,930円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,469,900円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の僧帽弁疾患市場は、2024年には28億米ドルと推定され、2024年から2031年までのCAGRは9％を示し、2031年には51億2,000万米ドルに達すると予測されます。

レポート範囲		レポート詳細
基準年	2023年	2024年の市場規模	28億米ドル
実績データ	2019～2023年	予測期間	2024～2031年
予測期間2024～2031年 CAGR：	9.00%	2031年の価値予測	51億2,000万米ドル

図.僧帽弁疾患市場シェア（%）、2024年地域別

僧帽弁疾患とは、心臓の左心房と左心室の間に位置する僧帽弁に影響を及ぼす疾患を指します。僧帽弁は、左心房から左心室への血流を調節する上で重要な役割を果たしています。僧帽弁疾患の一般的なタイプには、僧帽弁の狭窄や閉塞を引き起こす僧帽弁狭窄症や、僧帽弁を血液が逆流する僧帽弁閉鎖不全症などがあります。加齢、リウマチ熱、先天性心疾患、感染症などの要因が僧帽弁にダメージを与え、病気を引き起こす可能性があります。現在のところ、僧帽弁疾患の治療法はありませんが、治療は僧帽弁修復術や置換術などの処置によって、損傷した僧帽弁を修復または置換することを目的としています。

市場力学

僧帽弁疾患の世界市場は、心臓弁の加齢変性により僧帽弁疾患を発症しやすい老年人口が世界的に増加していることが原動力となっています。発展途上国におけるリウマチ性心疾患の有病率の増加は、予測期間中の市場成長を促進する可能性があります。しかし、僧帽弁の修復や置換手術に伴う高額な費用と熟練したヘルスケア専門家の不足が市場成長の妨げになる可能性があります。新しい僧帽弁修復技術や技術の開発が進行中であるため、市場プレイヤーにとって有利な成長機会が存在します。

この調査の主な特徴

当レポートでは、世界の僧帽弁疾患市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模および複合年間成長率（CAGR%）を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の僧帽弁疾患市場における主要企業プロファイルを掲載しています。

主な企業は、Edwards Lifesciences Corporation、Medtronic Plc、Abbott Laboratories、Boston Scientific Corporation、Corcym UK Limited、Artivion, Inc.、ShockWave Medical, Inc.、Valcare Medical、Braile Biomedica、Labcor Laboratorios Ltda、Zydus Lifesciences Limited、Affluent Medical、Teva Pharmaceutical Industries Ltd.、Bayer AG、Novartis AGなどです。

このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

僧帽弁膜疾患の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

世界の僧帽弁膜疾患市場の分析に使用される様々な戦略マトリックスを通じて、利害関係者は意思決定が容易になります。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 2.80 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.00%	2031 Value Projection:	US$ 5.12 Bn

Mitral valve disease refers to conditions that affect the mitral valve located between the left atrium and left ventricle of the heart. Mitral valve plays a key role in regulating blood flow from the left atrium to the left ventricle. Some common types of mitral valve disease include mitral valve stenosis, which causes narrowing or blockage of the mitral valve, and mitral valve regurgitation or insufficiency, which allows blood to flow backward through the mitral valve. Factors such as aging, rheumatic fever, congenital heart defects, and infections can damage the mitral valve and lead to diseases. Presently, there is no cure for mitral valve disease, however, treatments aim to repair or replace the damaged mitral valve via procedures such as mitral valve repair or replacement surgeries.

Market Dynamics

Global mitral valve disease market growth is driven by rising geriatric population globally who are more prone to develop mitral valve diseases due to age-related degeneration of heart valves. Increasing prevalence of rheumatic heart disease in developing nations can drive the market growth during the forecast period. However, high costs associated with mitral valve repair and replacement surgeries along with lack of skilled healthcare professionals can hamper the market growth. Ongoing development of novel mitral valve repair technologies and techniques present lucrative growth opportunities for market players.

Key Features of the Study

This report provides in-depth analysis of the global mitral valve disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global mitral valve disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Corcym UK Limited, Artivion, Inc., ShockWave Medical, Inc., Valcare Medical, Braile Biomedica, Labcor Laboratorios Ltda, Zydus Lifesciences Limited, Affluent Medical, Teva Pharmaceutical Industries Ltd., Bayer AG, and Novartis AG

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global mitral valve disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mitral valve disease market

Market Segmentation

Treatment Type Insights (Revenue, USD Bn, 2019 - 2031)
- Mitral Valve Repair
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair
- Mitral Valve Replacement
- Mechanical Valve Replacement
- Biological Valve Replacement
- Transcatheter Aortic Valve Replacement (TAVR)
- Cardiac Resynchronization Therapy (CRT)
- Biventricular Pacing
- Implantable Cardioverter Defibrillators (ICDs)
- Mitral Valve Therapeutics
- Pharmacological Treatments
- Device-Based Therapies
Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Mitral Valve Regurgitation
- Mitral Valve Stenosis
- Mitral Valve Prolapse
Device Type Insights (Revenue, USD Bn, 2019 - 2031)
- Surgical Instruments
- Heart-Lung Machines
- Surgical Staplers
- Sutures
- Implant Devices
- Mitral Valve Prostheses
- Repair Devices (e.g., annuloplasty rings)
- Diagnostic Devices
- Echocardiograms
- Cardiac Imaging Systems
End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Cardiac Rehabilitation Centers
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
Key Players Insights
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Corcym UK Limited
- Artivion, Inc.
- ShockWave Medical, Inc.
- Valcare Medical
- Braile Biomedica
- Labcor Laboratorios Ltda
- Zydus Lifesciences Limited
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Novartis AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Mitral Valve Disease Market, By Treatment Type
- Global Mitral Valve Disease Market, By Indication
- Global Mitral Valve Disease Market, By Device Type
- Global Mitral Valve Disease Market, By End User
- Global Mitral Valve Disease Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Mitral Valve Disease Market, By Treatment Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Mitral Valve Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair
Mitral Valve Replacement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mechanical Valve Replacement
- Biological Valve Replacement
- Transcatheter Aortic Valve Replacement (TAVR)
Cardiac Resynchronization Therapy (CRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biventricular Pacing
- Implantable Cardioverter Defibrillators (ICDs)
Mitral Valve Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Pharmacological Treatments
- Device-Based Therapies

5. Global Mitral Valve Disease Market, By Indication, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Mitral Valve Regurgitation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Mitral Valve Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Mitral Valve Prolapse
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Mitral Valve Disease Market, By Device Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Surgical Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Heart-Lung Machines
- Surgical Staplers
- Sutures
Implant Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mitral Valve Prostheses
- Repair Devices (e.g., annuloplasty rings)
Diagnostic Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Echocardiograms
- Cardiac Imaging Systems

7. Global Mitral Valve Disease Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiac Rehabilitation Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Mitral Valve Disease Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Edwards Lifesciences Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
Corcym UK Limited
Artivion, Inc.
ShockWave Medical, Inc.
Valcare Medical
Braile Biomedica
Labcor Laboratorios Ltda
Zydus Lifesciences Limited
Affluent Medical
Teva Pharmaceutical Industries Ltd.
Bayer AG
Novartis AG

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

僧帽弁疾患市場：治療タイプ別、適応症別、デバイスタイプ別、エンドユーザー別、地域別

Mitral Valve Disease Market, By Treatment Type, By Indication, By Device Type, By End User, By Geography

市場力学

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の僧帽弁疾患市場、治療タイプ別、2019～2031年

第5章世界の僧帽弁疾患市場、適応症別、2019～2031年

第6章世界の僧帽弁疾患市場、デバイスタイプ別、2019～2031年

第7章世界の僧帽弁疾患市場、エンドユーザー別、2019～2031年

第8章世界の僧帽弁疾患市場、地域別、2019～2031年

第9章競合情勢

第10章アナリストの推奨事項

第11章参考文献と調査手法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Mitral Valve Disease Market, By Treatment Type, 2019-2031, (USD Bn)

5. Global Mitral Valve Disease Market, By Indication, 2019-2031, (USD Bn)

6. Global Mitral Valve Disease Market, By Device Type, 2019-2031, (USD Bn)

7. Global Mitral Valve Disease Market, By End User, 2019-2031, (USD Bn)

8. Global Mitral Valve Disease Market, By Region, 2019 - 2031, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

僧帽弁疾患市場：治療タイプ別、適応症別、デバイスタイプ別、エンドユーザー別、地域別

Mitral Valve Disease Market, By Treatment Type, By Indication, By Device Type, By End User, By Geography

市場力学

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の僧帽弁疾患市場、治療タイプ別、2019～2031年

第5章 世界の僧帽弁疾患市場、適応症別、2019～2031年

第6章 世界の僧帽弁疾患市場、デバイスタイプ別、2019～2031年

第7章 世界の僧帽弁疾患市場、エンドユーザー別、2019～2031年

第8章 世界の僧帽弁疾患市場、地域別、2019～2031年

第9章 競合情勢

第10章 アナリストの推奨事項

第11章 参考文献と調査手法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Mitral Valve Disease Market, By Treatment Type, 2019-2031, (USD Bn)

5. Global Mitral Valve Disease Market, By Indication, 2019-2031, (USD Bn)

6. Global Mitral Valve Disease Market, By Device Type, 2019-2031, (USD Bn)

7. Global Mitral Valve Disease Market, By End User, 2019-2031, (USD Bn)

8. Global Mitral Valve Disease Market, By Region, 2019 - 2031, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の僧帽弁疾患市場、治療タイプ別、2019～2031年

第5章世界の僧帽弁疾患市場、適応症別、2019～2031年

第6章世界の僧帽弁疾患市場、デバイスタイプ別、2019～2031年

第7章世界の僧帽弁疾患市場、エンドユーザー別、2019～2031年

第8章世界の僧帽弁疾患市場、地域別、2019～2031年

第9章競合情勢

第10章アナリストの推奨事項

第11章参考文献と調査手法